COM:ARCUSBIO
Arcus Biosciences
- Stock
Last Close
14.28
22/11 21:00
Market Cap
1.27B
Beta: -
Volume Today
534.33K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|
average inventory | -3.58M - | -384.81M 10,635.26% | -467.22M 21.42% | -86M 81.59% | |||||
average payables | 3.84M - | 3.46M 9.95% | 3.90M 12.77% | 10.19M 161.16% | 12.97M 27.26% | 15.13M 16.64% | 18.50M 22.27% | ||
average receivables | 215K - | 54K 74.88% | 107.50K 99.07% | 915K 751.16% | 374.26M 40,802.73% | 394.91M 5.52% | 42.50M 89.24% | ||
book value per share | 4.05 - | 3.62 10.73% | 6.79 87.68% | 3.74 44.91% | 9.17 145.18% | 12.14 32.47% | 11.99 1.24% | 6.24 47.94% | |
capex per share | -0.17 - | -0.13 22.37% | -0.11 16.56% | -0.04 59.38% | -0.06 26.92% | -0.38 575.01% | -0.22 41.79% | -0.32 48.07% | |
capex to depreciation | -3.12 - | -2.11 32.33% | -1.02 51.61% | -0.54 47.33% | -0.73 35.49% | -6.79 830.92% | -2 70.53% | -3 50% | |
capex to operating cash flow | 0.32 - | 0.22 30.51% | 0.09 60.44% | 0.03 69.90% | -0.03 204.87% | 0.10 470.44% | -0.03 126.91% | 0.08 386.27% | |
capex to revenue | -3.90 - | -0.45 88.52% | -0.13 71.36% | -0.04 69.29% | -0.07 72.82% | -0.11 57.31% | -0.21 91.45% | ||
cash per share | 4.03 - | 4.13 2.53% | 7.41 79.47% | 4.30 42.03% | 13.30 209.52% | 7.21 45.81% | 18.42 155.61% | 10.26 44.31% | |
days of inventory on hand | |||||||||
days payables outstanding | |||||||||
days sales outstanding | 6.46 - | 3.63 43.84% | 3.21 11.44% | 8.00 148.92% | 711.94 8,804.54% | 140.13 80.32% | 131.03 6.50% | ||
debt to assets | 0.02 - | 0.02 33.03% | 0.05 113.99% | 0.06 19.02% | 0.11 92.12% | 0.01 - | |||
debt to equity | 0.02 - | 0.03 25.74% | 0.06 126.70% | 0.09 47.62% | 0.20 136.40% | 0.02 - | |||
dividend yield | |||||||||
earnings yield | -0.04 - | -0.07 70.46% | -0.13 81.27% | -0.17 28.96% | -0.08 52.19% | 0.02 122.97% | -0.24 1,351.03% | -0.22 7.83% | |
enterprise value | 352.27M - | 624.93M 77.40% | 301.77M 51.71% | 384.71M 27.48% | 1.26B 228.68% | 2.77B 119.35% | 927.00M 66.58% | 1.30B 39.96% | |
enterprise value over ebitda | -20.88 - | -12.29 41.13% | -5.38 56.24% | -4.34 19.40% | -10.13 133.54% | 50.52 598.78% | -3.51 106.95% | -4.46 26.97% | |
ev to operating cash flow | -27.21 - | -24.94 8.36% | -7.02 71.86% | -5.24 25.39% | 11.37 317.19% | -10.83 195.19% | 2.12 119.55% | -4.24 300.33% | |
ev to sales | 442.27 - | 36.13 91.83% | 25.65 29.01% | 16.31 36.40% | 7.24 55.59% | 8.28 14.26% | 11.09 33.98% | ||
free cash flow per share | -0.69 - | -0.72 3.52% | -1.35 87.91% | -1.72 27.41% | 1.97 214.69% | -4.07 306.44% | 7.78 290.91% | -4.46 157.35% | |
free cash flow yield | -0.04 - | -0.04 3.52% | -0.13 196.60% | -0.17 35.86% | 0.08 144.62% | -0.10 232.42% | 0.38 473.61% | -0.23 162.10% | |
graham net net | 3.62 - | 3.27 9.76% | 6.26 91.41% | 3.40 45.63% | 8.33 144.77% | -1.04 112.52% | 4.88 567.92% | 2.13 56.37% | |
graham number | 8.17 - | 10.07 23.36% | 14.79 46.81% | 12.07 18.38% | 20.95 73.58% | 14.43 31.13% | 36.26 151.27% | 24.14 33.43% | |
income quality | 0.72 - | 0.47 34.46% | 0.87 83.65% | 0.87 0.03% | -0.90 204.34% | -4.85 435.88% | -1.64 66.17% | 1.00 160.76% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -11.15 - | 208.65 - | -140 167.10% | -170 21.43% | |||||
interest debt per share | 0.07 - | 0.32 328.85% | 0.22 31.28% | 0.79 261.93% | 2.47 213.63% | 0.04 98.52% | 0.18 381.24% | ||
inventory turnover | |||||||||
invested capital | 0.02 - | 0.03 25.74% | 0.06 126.70% | 0.09 47.62% | 0.20 136.40% | 0.02 - | |||
market cap | 417.43M - | 723.36M 73.29% | 372.84M 48.46% | 442.64M 18.72% | 1.42B 221.39% | 2.80B 97.14% | 1.13B 59.60% | 1.41B 24.75% | |
net current asset value | 89.45M - | 140.25M 56.79% | 218.97M 56.12% | 153.44M 29.93% | 465.10M 203.12% | -69.15M 114.87% | 379M 648.08% | 198M 47.76% | |
net debt to ebitda | 3.86 - | 1.94 49.87% | 1.27 34.57% | 0.65 48.45% | 1.27 93.98% | -0.57 144.60% | 0.78 238.08% | 0.40 48.91% | |
net income per share | -0.73 - | -1.25 70.46% | -1.43 14.84% | -1.73 20.94% | -2.13 22.89% | 0.76 135.80% | -4.87 739.27% | -4.15 14.87% | |
operating cash flow per share | -0.53 - | -0.59 11.72% | -1.24 110.89% | -1.68 34.96% | 2.03 221.03% | -3.70 282.22% | 7.99 316.27% | -4.14 151.72% | |
payables turnover | |||||||||
receivables turnover | 56.52 - | 100.64 78.06% | 113.64 12.92% | 45.65 59.83% | 0.51 98.88% | 2.60 408.04% | 2.79 6.95% | ||
research and ddevelopement to revenue | 33.42 - | 5.94 82.21% | 5.23 11.97% | 2.06 60.71% | 0.67 67.43% | 2.57 284.07% | 2.91 13.01% | ||
return on tangible assets | -0.16 - | -0.28 70.12% | -0.18 35.27% | -0.37 107.24% | -0.15 59.59% | 0.03 121.97% | -0.20 698.17% | -0.28 41.23% | |
revenue per share | 0.03 - | 0.24 626.61% | 0.34 41.85% | 1.41 313.29% | 5.52 290.58% | 2.04 63.00% | 1.58 22.66% | ||
roe | -0.18 - | -0.34 90.94% | -0.21 38.81% | -0.46 119.55% | -0.23 49.88% | 0.06 127.03% | -0.41 747.28% | -0.66 63.51% | |
roic | -0.18 - | -0.34 86.19% | -0.25 26.01% | -0.46 82.13% | -0.21 54.12% | 0.05 122.07% | -0.43 1,020.87% | -0.72 67.49% | |
sales general and administrative to revenue | 5.40 - | 1.62 69.95% | 1.68 3.56% | 0.55 67.47% | 0.19 65.49% | 0.93 391.84% | 1 7.69% | ||
shareholders equity per share | 4.05 - | 3.62 10.73% | 6.79 87.68% | 3.74 44.91% | 9.17 145.18% | 12.14 32.47% | 11.99 1.24% | 6.24 47.94% | |
stock based compensation to revenue | 0.35 - | 0.46 32.39% | 0.60 29.10% | 0.28 52.98% | 0.14 49.42% | 0.58 307.51% | 0.62 7.51% | ||
tangible asset value | 99.46M - | 153.87M 54.70% | 234.94M 52.69% | 163.84M 30.26% | 502.30M 206.58% | 841.45M 67.52% | 657M 21.92% | 462M 29.68% | |
tangible book value per share | 4.05 - | 3.62 10.73% | 6.79 87.68% | 3.74 44.91% | 9.17 145.18% | 12.14 32.47% | 11.99 1.24% | 6.24 47.94% | |
working capital | 94.14M - | 164.14M 74.35% | 242.01M 47.44% | 170.00M 29.76% | 613.42M 260.84% | 515.21M 16.01% | 874M 69.64% | 647M 25.97% |
All numbers in USD (except ratios and percentages)